Selective CK1α degraders exert antiproliferative activity against a broad range of human cancer cell linesGisele Nishiguchi, Zoran Ranković, Sherif Abdelhamed et al.|Nature Communications|2024Cited by 50
Abstract LB040: Identification of a potent and selective PPIL4 degrader with therapeutic potential from a library of Cereblon modulatorsYunchao Chang, Charles G. Mullighan, Vanshita Goel et al.|Cancer Research|2026Cited by 0